167 related articles for article (PubMed ID: 16006858)
1. Measuring the quality of care for localized prostate cancer.
Miller DC; Montie JE; Wei JT
J Urol; 2005 Aug; 174(2):425-31. PubMed ID: 16006858
[TBL] [Abstract][Full Text] [Related]
2. Quality of care indicators for prostate cancer: progress toward consensus.
Miller DC; Saigal CS
Urol Oncol; 2009; 27(4):427-34. PubMed ID: 19573774
[TBL] [Abstract][Full Text] [Related]
3. Treatment choice and quality of care for men with localized prostate cancer.
Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS
Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
[TBL] [Abstract][Full Text] [Related]
4. Use of quality indicators to evaluate the care of patients with localized prostate carcinoma.
Miller DC; Litwin MS; Sanda MG; Montie JE; Dunn RL; Resh J; Sandler H; Wei JT
Cancer; 2003 Mar; 97(6):1428-35. PubMed ID: 12627506
[TBL] [Abstract][Full Text] [Related]
5. Variations in quality of care for men with early-stage prostate cancer.
Spencer BA; Miller DC; Litwin MS; Ritchey JD; Stewart AK; Dunn RL; Gay EG; Sandler HM; Wei JT
J Clin Oncol; 2008 Aug; 26(22):3735-42. PubMed ID: 18669460
[TBL] [Abstract][Full Text] [Related]
6. Quality-of-care indicators for early-stage prostate cancer.
Spencer BA; Steinberg M; Malin J; Adams J; Litwin MS
J Clin Oncol; 2003 May; 21(10):1928-36. PubMed ID: 12743145
[TBL] [Abstract][Full Text] [Related]
7. Erectile function outcome reporting after clinically localized prostate cancer treatment.
Burnett AL; Aus G; Canby-Hagino ED; Cookson MS; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus S; Liebert M; Moul JW; Tangen C; Thrasher JB; Thompson I;
J Urol; 2007 Aug; 178(2):597-601. PubMed ID: 17570435
[TBL] [Abstract][Full Text] [Related]
8. Assessing the quality of prostate cancer care.
Penson DF
Curr Opin Urol; 2008 May; 18(3):297-302. PubMed ID: 18382239
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States.
Ritchey J; Gay EG; Spencer BA; Miller DC; Wallner LP; Stewart AK; Dunn RL; Litwin MS; Wei JT
J Urol; 2012 Sep; 188(3):769-74. PubMed ID: 22818140
[TBL] [Abstract][Full Text] [Related]
10. Defining high quality health care.
Cooperberg MR; Birkmeyer JD; Litwin MS
Urol Oncol; 2009; 27(4):411-6. PubMed ID: 19573771
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
12. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.
Dahm P; Yeung LL; Chang SS; Cookson MS
J Urol; 2008 Aug; 180(2):451-9; discussion 460. PubMed ID: 18550100
[TBL] [Abstract][Full Text] [Related]
13. Development of prostate cancer quality indicators: a modified Delphi approach.
Gagliardi AR; Fleshner N; Langer B; Stern H; Brown AD
Can J Urol; 2005 Oct; 12(5):2808-15. PubMed ID: 16274516
[TBL] [Abstract][Full Text] [Related]
14. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
Giraldes Mdo R
Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
[TBL] [Abstract][Full Text] [Related]
15. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
[TBL] [Abstract][Full Text] [Related]
16. Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer.
Owen JB; White JR; Zelefsky MJ; Wilson JF
J Am Coll Radiol; 2009 Jun; 6(6):442-7. PubMed ID: 19467491
[TBL] [Abstract][Full Text] [Related]
17. Candidate quality of care indicators for localized bladder cancer.
Cooperberg MR; Porter MP; Konety BR
Urol Oncol; 2009; 27(4):435-42. PubMed ID: 19573775
[TBL] [Abstract][Full Text] [Related]
18. Proposed quality measures for palliative care in the critically ill: a consensus from the Robert Wood Johnson Foundation Critical Care Workgroup.
Mularski RA; Curtis JR; Billings JA; Burt R; Byock I; Fuhrman C; Mosenthal AC; Medina J; Ray DE; Rubenfeld GD; Schneiderman LJ; Treece PD; Truog RD; Levy MM
Crit Care Med; 2006 Nov; 34(11 Suppl):S404-11. PubMed ID: 17057606
[TBL] [Abstract][Full Text] [Related]
19. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
[TBL] [Abstract][Full Text] [Related]
20. Quality of life for men receiving a second treatment for prostate cancer.
Arredondo SA; Latini DM; Sadetsky N; Kawakami J; Pasta DJ; DuChane J; Carroll PR;
J Urol; 2007 Jan; 177(1):273-8; discussion 278-9. PubMed ID: 17162062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
